Skip to Content

93 782 (Tamoxifen Citrate 20 mg)

Pill with imprint 93 782 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Teva Pharmaceuticals USA.

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 782

Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate 20 mg 93 782 Front
Tamoxifen citrate 20 mg 93 782 Back
Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate 20 mg 93 782

Tamoxifen Citrate

Imprint
93 782
Strength
20 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Hormones/antineoplastics, Selective estrogen receptor modulators
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
croscarmellose sodium, hypromellose 2910 (5 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 400, povidone k30, corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-0782 Teva Pharmaceuticals USA, Inc.
51862-0446 Libertas Pharma
54868-4287 Physicians Total Care Inc. (repackager)
54569-5857 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Related Images for "93 782"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.